Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | THRA | P10827 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | GBA1 | P04062 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20142522 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL4260574 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL627232 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791152 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL2322366 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL9398013 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL12791220 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL20746956 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL21126455 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A | |
| SCHEMBL11262421 | 1.00 | DNM1 (0.50) | DNM1THRBTSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538575-B1 | HIGH CIS-1,4 BLOCK COPOLYMERS OF POLYBUTADIENE AND POLYISOPRENE | BRIDGESTONE CORP (JP) | 2024-03-13 | — | — | EP | disclosed |
| US-11884767-B2 | High cis-1,4 block copolymers of polybutadiene and polyisoprene | BRIDGESTONE CORPORATION (JP) | 2024-01-30 | — | — | US | disclosed |
| US-11696953-B2 | Poly(beta-amino esters) and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-11 | — | — | US | disclosed |
| US-20220119573-A1 | HIGH CIS-1,4 BLOCK COPOLYMERS OF POLYBUTADIENE AND POLYISOPRENE | BRIDGESTONE CORPORATION (JP) | 2022-04-21 | — | — | US | disclosed |
| US-11230622-B2 | High cis-1,4 block copolymers of polybutadiene and polyisoprene | BRIDGESTONE CORPORATION (JP) | 2022-01-25 | — | — | US | disclosed |
| US-20210388196-A1 | GENE DELIVERY CARRIER | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-12-16 | — | — | US | disclosed |
| EP-3538575-A1 | HIGH CIS-1,4 BLOCK COPOLYMERS OF POLYBUTADIENE AND POLYISOPRENE | Bridgestone Corporation (JP) | 2019-09-18 | — | — | EP | disclosed |
| CN-110139882-A | High cis-1, 4 block copolymers of polybutadiene and polyisoprene | 株式会社普利司通 | 2019-08-16 | — | — | CN | disclosed |
| WO-2018089635-A1 | HIGH CIS-1,4 BLOCK COPOLYMERS OF POLYBUTADIENE AND POLYISOPRENE | BRIDGESTONE CORPORATION (JP) | 2018-05-17 | — | — | WO | disclosed |
| US-20160009657-A1 | AMINE-CONTAINING LIPIDS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-01-14 | — | — | US | disclosed |
| US-9006487-B2 | Amine-containing lipids and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2015-04-14 | — | — | US | disclosed |
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | SHIRE HUMAN GENETIC THERAPIES, INC. | 2011-03-03 | — | — | US | disclosed |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110052673-A1 | THERAPEUTIC COMPOSITIONS | PHOSPHO1, SGMS1, APOB | DNM1 1206/4885THRB 3156/4885TSHR 2608/4885 |
| US-20110009641-A1 | Amine-containing lipids and uses thereof | PHOSPHO1, CHMP4B, SGMS1 | DNM1 946/4885THRB 4746/4885TSHR 4001/4885 |
| US-20210388196-A1 | GENE DELIVERY CARRIER | PAICS, PBDC1, BCAT1 | DNM1 4619/4885THRB 2797/4885TSHR 3794/4885 |
| US-11696953-B2 | Poly(beta-amino esters) and uses thereof | BCAT1, BCAT2, SNRPE | DNM1 2479/4885THRB 1842/4885TSHR 4387/4885 |
| US-20160009657-A1 | AMINE-CONTAINING LIPIDS AND USES THEREOF | PHOSPHO1, CHMP4B, SGMS1 | DNM1 946/4885THRB 4746/4885TSHR 4001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.